Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27056184 | 1.00 | HCRTR1 (0.63) | HCRTR1HCRTR2 | |
| SCHEMBL1671087 | 1.00 | HCRTR1 (0.63) | HCRTR1HCRTR2 | |
| SCHEMBL17793770 | 0.87 | HCRTR1 (0.52) | HCRTR1HCRTR2 | |
| SCHEMBL19345643 | 0.84 | HCRTR1 (0.70) | HCRTR1HCRTR2 | |
| SCHEMBL27056148 | 0.84 | HCRTR1 (0.47) | HCRTR1HCRTR2 | |
| SCHEMBL11907815 | 0.83 | HCRTR1 (0.56) | HCRTR1HCRTR2 | |
| SCHEMBL30465902 | 0.83 | HCRTR1 (0.54) | HCRTR1HCRTR2 | |
| SCHEMBL11907807 | 0.83 | HCRTR1 (0.56) | HCRTR1HCRTR2 | |
| SCHEMBL27029922 | 0.83 | HCRTR1 (0.71) | HCRTR1HCRTR2 | |
| SCHEMBL1586869 | 0.83 | HCRTR1 (0.59) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4588921-A1 | FREE BASE CRYSTAL FORM OF POLYCYCLIC COMPOUND OF NITROGEN-CONTAINING HETEROCYCLE, AND PREPARATION METHOD THEREFOR | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) | 2025-07-23 | — | — | EP | disclosed |
| CN-116217593-B | Octahydropyrrolo [3,4-c ] pyrrole methyl ketone derivative and application thereof | 江苏恩华药业股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119866339-A | Free base crystalline forms of nitrogen-containing heterocyclic polycyclic compounds and methods of making the same | 江苏豪森药业集团有限公司 | 2025-04-22 | — | — | CN | disclosed |
| US-20240208981-A1 | NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2024-06-27 | — | — | US | disclosed |
| CN-117700416-A | Salts of polycyclic compounds containing nitrogen heterocycles and process for preparing the same | 江苏豪森药业集团有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-4310089-A1 | NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2024-01-24 | — | — | EP | disclosed |
| CN-116981670-A | Polycyclic compound containing nitrogen heterocycle, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116217593-A | Octahydropyrrolo [3,4-c ] pyrrole methyl ketone derivative and application thereof | 江苏恩华药业股份有限公司 | 2023-06-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208981-A1 | NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | HCRTR1, HCRTR2, CCKBR | HCRTR1 1/4885HCRTR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.